GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: Arelili® | Ariely® | HTI-1088 | HTI1088 | SHR-1316 | SHR1316
adebrelimab is an approved drug (China NMPA (2023))
Compound class:
Antibody
Comment: Adebrelimab (SHR-1316; HTI-1088) is a chimeric humanized IgG4κ anti-PD-L1 monoclonal antibody.
|
Classification ![]() |
|
| Compound class | Antibody |
| Approved drug? | Yes. China NMPA (2023) |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 11300 | adebrelimab |
Synonyms ![]() |
| Arelili® | Ariely® | HTI-1088 | HTI1088 | SHR-1316 | SHR1316 |
Database Links ![]() |
|
| Specialist databases | |
| IMGT/mAb-DB | 999 |
| Other databases | |
| GtoPdb PubChem SID | 491299867 |
| Search PubMed clinical trials | adebrelimab |
| Search PubMed titles | adebrelimab |
| Search PubMed titles/abstracts | adebrelimab |